Registry of COPD Patients Who Undergo Outpatient Treatment or Are Under Surveillance at Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow
Sponsor study identifier
observational
2,000
1 country
1
Study Start
December 2016
Actual (reported)Primary Completion
January 2019
Actual (reported)Study Completion
February 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
To describe the clinical profile of COPD patient who is under outpatient surveillance at polyclinic institutions of Moscow (including demographic data (age, gender, ethnicity, occupation), smoking status, disease duration, disease severity grade, distribution by disease phenotype, disease exacerbation rate in the setting of real-life clinical practice).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 14, 2016
Actual (reported)August 2, 2016
Actual (reported)December 2016
Actual (reported)January 2019
Actual (reported)February 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
COPD prevalence among patients registered in the healthcare system of Moscow (under outpatient surveillance at polyclinic institutions of Moscow).
COPD prevalence among patients registered in the healthcare system of Moscow (under outpatient surveillance at polyclinic institutions of Moscow).
1 day
To describe the clinical profile of COPD patient in Moscow (including demographic data (age, gender, ethnicity, occupation), smoking status, disease duration, disease severity grade
To describe the clinical profile of COPD patient who is under outpatient surveillance at polyclinic institutions of Moscow (including demographic data (age, gender, ethnicity, occupation), smoking status, disease duration, disease severity grade, distribution by disease phenotype, disease exacerbation rate in the setting of real-life clinical practice).
1 day
Percentage of patients with different disease phenotypes among outpatients
1 day
Percentage of prescriptions of medicinal products to COPD patients depending on disease severity grade in the setting of real-life clinical practice
1 year
Distribution (%) of COPD patients who seek attention from primary medical care physicians by severity of airway obstruction
1 year
Mean number of exacerbations requiring medical attention (outpatient prescription of oral corticosteroids and/or antibiotics) in the last year in COPD patients
1 year
Mean number of hospitalizations in the last year in COPD patients
1 year
Randomly selected polyclinic institutions of Moscow will take part in the study and enrol into the registry 2000 patients for representativeness of sample for analysis of COPD prevalence in Moscow. The patient population includes male and female patients over 40 years of age, smokers or ex-smokers, under outpatient surveillance at polyclinic institutions of Moscow with diagnosis codes according to ICD J40 - J44 and diagnosed COPD, as confirmed by spirometry results
Russian respiratory Society
Moscow, 105077, Russia
Andrey S Belevskiy, M.D., Ph.D.
Interregional Public Organization "Russian Respiratory Society'
First Submitted
July 14, 2016
First Posted
August 2, 2016
Study Start
December 2016
Actual (reported)Primary Completion
January 2019
Actual (reported)Contact the study team to confirm eligibility.
Study Completion
February 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 4, 2019
Record last verified: 2019-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: